Journal ArticleOPEN ACCESS

Creutzfeldt‐Jakob disease with neuroleptic malignant syndrome

  • Čiauškaitė J
  • Puleikytė I
  • Jesmanas S
  • et al.
Clinical Case Reports (2021) 9(8)
DOI: 10.1002/ccr3.4699
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Creutzfeldt‐Jakob disease (CJD) is a rare rapidly progressive fatal neurodegenerative disease. Neuroleptic malignant syndrome (NMS) is a complication of antipsychotic medications which may be used to treat neuropsychiatric symptoms of CJD. We present a case of a 51‐year‐ old woman with CJD who developed NMS after being prescribed quetiapine.

Cite

CITATION STYLE

APA

Čiauškaitė, J., Puleikytė, I., Jesmanas, S., Jurkevičienė, G., Vaitkus, A., & Rastenytė, D. (2021). Creutzfeldt‐Jakob disease with neuroleptic malignant syndrome. Clinical Case Reports, 9(8). https://doi.org/10.1002/ccr3.4699

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free